Further analysis of scRNA-seq results of CAR-T cells derived from the LBCL patients exhibiting partial or non-response revealed that the compromised death receptor signaling pathway in tumor cells resulted in the failure of the cytotoxic killing function of CD19-CAR-T cells. Here, CD19 is linked to neoplasm.